Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Opicapone on Warfarin Pharmacokinetics in Healthy Volunteers
NCT02169440Phase 1Completed
- Sponsor
- BIAL
- Start
- Jun 2009
- Primary completion
- Jul 2009
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of opicapone in Parkinson's disease (PD), sponsored by BIAL. Started Jun 2009; status: completed.
02
Drugs
opicapone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT02169440.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02169440.